Immunovant stock down on dismal third-quarter fiscal 2025 results. It is on track to initiate 10 studies on IMVT-1402 across various autoimmune indications.

DAVENPORT & Co LLC reduced its position in shares of argenx SE (NASDAQ:ARGX – Free Report) by 5.1% during the fourth quarter, ...

BOSTON—Crystal Adam, President of Research & Development at Tango Therapeutics, Inc. (NASDAQ:TNGX), recently sold a total of ...

BOSTON—Barbara Weber, the Chief Executive Officer of Tango Therapeutics, Inc. (NASDAQ:TNGX), a $350 million market cap biotech company, recently sold a portion of her holdings in the company.

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Albert Fiori was diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy or CIDP, a rare autoimmune disease that affects his eye, one arm and one leg. But he is not letting that stop him from ...

Pacer Advisors Inc. decreased its position in argenx SE (NASDAQ:ARGX – Free Report) by 5.2% during the fourth quarter, Holdings Channel reports. The fund owned 789 shares of the company’s stock after ...

BofA raised the firm’s price target on Argenx (ARGX) to $774 from $770 and keeps a Buy rating on the shares. The company pre-announced Q4 ...

THE family of a "beloved father and husband" who took his own life after Covid-19 vaccine complications are fighting for justice.

Denver Location Boasts Private Infusion Suites for Addressing Patients’ Specialty Therapy Needs Soleo Health, an innovative ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...